Sugden MC, Holness MJ (2003). "Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.". Curr. Drug Targets Immune Endocr. Metabol. Disord.2 (2): 151–65. PMID 12476789.
Sugden MC, Holness MJ (2003). "Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.". Am. J. Physiol. Endocrinol. Metab.284 (5): E855–62. doi:10.1152/ajpendo.00526.2002. PMID 12676647.
Gudi R, Bowker-Kinley MM, Kedishvili NY, et al. (1996). "Diversity of the pyruvate dehydrogenase kinase gene family in humans.". J. Biol. Chem.270 (48): 28989–94. PMID 7499431.
Baker JC, Yan X, Peng T, et al. (2000). "Marked differences between two isoforms of human pyruvate dehydrogenase kinase.". J. Biol. Chem.275 (21): 15773–81. doi:10.1074/jbc.M909488199. PMID 10748134.
Kolobova E, Tuganova A, Boulatnikov I, Popov KM (2001). "Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.". Biochem. J.358 (Pt 1): 69–77. PMID 11485553.
Korotchkina LG, Patel MS (2001). "Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.". J. Biol. Chem.276 (40): 37223–9. doi:10.1074/jbc.M103069200. PMID 11486000.
Tuganova A, Boulatnikov I, Popov KM (2002). "Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.". Biochem. J.366 (Pt 1): 129–36. doi:10.1042/BJ20020301. PMID 11978179.
Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A.99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
Spriet LL, Tunstall RJ, Watt MJ, et al. (2005). "Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting.". J. Appl. Physiol.96 (6): 2082–7. doi:10.1152/japplphysiol.01318.2003. PMID 14966024.
Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res.14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
Kato M, Chuang JL, Tso SC, et al. (2005). "Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.". EMBO J.24 (10): 1763–74. doi:10.1038/sj.emboj.7600663. PMID 15861126.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
Tso SC, Kato M, Chuang JL, Chuang DT (2006). "Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.". J. Biol. Chem.281 (37): 27197–204. doi:10.1074/jbc.M604339200. PMID 16849321.
Devedjiev Y, Steussy CN, Vassylyev DG (2007). "Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.". J. Mol. Biol.370 (3): 407–16. doi:10.1016/j.jmb.2007.04.083. PMID 17532006.
Degenhardt T, Saramäki A, Malinen M, et al. (2007). "Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.". J. Mol. Biol.372 (2): 341–55. doi:10.1016/j.jmb.2007.06.091. PMID 17669420.
Kato M, Li J, Chuang JL, Chuang DT (2007). "Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.". Structure15 (8): 992–1004. doi:10.1016/j.str.2007.07.001. PMID 17683942.